logo

For the Inventor, By the Inventor

Califon, NJ, United States of America

Charles F Schwender

This inventor holds 51 USPTO granted patents, primarily in Pharmaceutical Compounds (CPC class 5442). Top assignees: Warner-Lambert Company, Ortho Pharmaceutical Corporation, Millennium Pharmaceuticals Limited. Active years: 1976-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles F Schwender. Retrieved from https://idiyas.com/inventor/charles-f-schwender

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 341(Granted Patents)

Forward Citations (Not Self Cited) = 335(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Lebanon, NJ (US) (1976 - 1979)
  • Dexter, MI (US) (1978 - 1983)
  • Gladstone, NJ (US) (1988 - 1992)
  • Califon, NJ (US) (1987 - 1998)
  • Dover, MA (US) (1999 - 2000)
  • Glen Gardner, NJ (US) (2001 - 2002)

Company Filing History:

goldMedal30 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal16 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
bronzeMedal4 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
4. 1 out of 5 
 
Leukosite, Inc.
 patents

Years Active: 1976-2002

Loading Chart...
Areas of Expertise:
MCP-1 Antagonists
Angiotensin II Inhibitors
Enolamides
Purine Derivatives
Thiacylcalkeno Pyridines
Dibenzazulenes
Bone Wasting Treatments
Osteoporosis
Pharmaceutical Compositions
Guanine Derivatives
Triazoles
Phosphonic Acids
51 patents (USPTO):Explore Patents
1. 6458806 - Aryl alkenamides derivatives as MCP-1 antagonists (2002-10-01),
2. 6323206 - Chemokine receptor antagonists and methods of use therefor (2001-11-27),
3. 6281212 - Chemokine receptor antagonists and methods of use therefor (2001-08-28),
4. 6274556 - Inhibitors of MadCAM-1-mediated interactions and methods of use therefor (2001-08-14),
5. 6037324 - Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor (2000-03-14),
6. 5994563 - Arylmethylphosphonic acid derivatives useful in treating bone wasting (1999-11-30),
7. 5834521 - Substituted dibenz (A F)azulenes and methods of preparation (1998-11-10),
8. 5532226 - Trifluoromethybenzylphosphonates useful in treating osteoporosis (1996-07-02),
9. 5508419 - Substituted triazoles as angiotensin II inhibitors (1996-04-16),
10. 5508273 - Substituted phosphonic acids and derivatives useful in treating bone (1996-04-16),
11. 5347011 - Substituted triazoles as angiotensin II inhibitors (1994-09-13),
12. 5300687 - Trifluoromethylbenzylphosphonates useful in treating osteoporosis (1994-04-05),
13. 5240953 - Substituted triazoles as angiotensin II inhibitors (1993-08-31),
14. 5098906 - Purine derivatives (1992-03-24),
15. 5075440 - Novel pyrido[2,3-f](1,4)thiazepines and (1991-12-24),

Title: The Innovative Journey of Charles F Schwender

Introduction: Charles F Schwender, a visionary inventor hailing from Califon, NJ (US), has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Charles F Schwender's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a wearable health monitoring device that tracks vital signs in real-time.

Career Highlights: With a career spanning over two decades, Charles F Schwender has established himself as a pioneer in the field of technology, holding numerous patents in various sectors such as IoT, healthcare, and consumer electronics. His innovative solutions have garnered recognition for their impact on improving daily lives.

Collaborations: Throughout his career, Charles F Schwender has collaborated with leading tech companies, research institutions, and universities to further develop and commercialize his inventions. His collaborative spirit has led to the successful implementation of cutting-edge technologies in the market.

Conclusion: Charles F Schwender's relentless pursuit of innovation and his passion for creating solutions that address real-world challenges have solidified his position as a respected inventor in the industry. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…